Clinical trials recruiting in Garfield Heights, Ohio

Phase breakdown

Conditions recruiting in Garfield Heights, Ohio

Recruiting trials in Garfield Heights, Ohio

• A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression
  NCT03887715 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female)
• ALTO-207 in Adults With Treatment-resistant Depression (TRD)
  NCT07553637 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female)
• BTL-699-2 and HPM-6000UF Devices for the Improvement of Depressive Symptoms and Urinary Incontinence in Postpartum and Early Post-Childbirth Women
  NCT07413692 · Phase: Not applicable (e.g. observational or device study) · Ages: 22 Years to 60 Years · Sex: Female
• Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
  NCT06372964 · Phase: Phase 3 · Ages: 10 Years to 17 Years · Sex: All (male and female)
• Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder
  NCT06229210 · Phase: Phase 3 · Ages: 5 Years to 17 Years · Sex: All (male and female)
• Safety and Tolerability of Open-Labeled Iloperidone in Adolescents
  NCT05648591 · Phase: Phase 4 · Ages: 12 Years to 17 Years · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Garfield Heights, Ohio?

6 recruiting trials have at least one study site in Garfield Heights, Ohio.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.